Evaluation of Hypo-Safe Hypoglycaemia Alarm Device - the Pilot 2 Study - Healthy Subjects
Evaluation of Hypo-Safe Hypoglycaemia Alarm Device - the Pilot 2 Study - Healthy Subjects
The objective of this pilot trial is to demonstrate the safety and the performance of the Hyposafe hypoglycaemia alarm device before conducting clinical trials in type 1 diabetes patients.
Inclusion Criteria:
Exclusion Criteria:
Severe cardiac disease
Previous stroke or cerebral haemorrhage and any other structural cerebral disease
Active cancer or cancer diagnosis within the past five years
Uraemia defined as s-creatinine above 3 times upper reference value
Liver disease defined as s-alanine aminotransferase (s-ALAT) above 3 times upper reference interval
Epilepsy
Use of antiepileptic drugs for any purposes
Clinical important hearing impairment
Use of active implantable medical device including
Use of following drugs
Abuse of alcohol (defined as consumption of > 250g alcohol (in Danish: 21 "genstande")) per week or abuse of any other neuro-active substances
Infection at the site of device-implantation
Any haemorrhagic disease
Diving (snorkel diving allowed) or parachute jumping
Patients that are judged incapable to understand the patient information or who are unlikely to complete the investigation for any reason
Persons operating MRI scanners.
Persons operating handheld transceivers for communication (e.g. within the police, medical, fire, air traffic control, marine or military).
Persons working at broadcast stations for television or FM/DAB radio.
Persons performing extreme sport.